HCP Live

ASRS 2019 Street Team: Raj K. Maturi, MD

Article
Conference|ASRS

ICYMI: Abicipar Phase II MAPLE Trial supports improved safety for patients with nAMD following a Modified Manufacturing Process

Raj K. Maturi, MD, discusses phase II data from the abicipar Phase II MAPLE Trial for patients with AMD at the 2019 annual ASRS conference.

Related Videos
Related Content
I-SCREEN project set to use AI for AMD diagnosis across Europe

I-SCREEN project set to use AI for AMD diagnosis across Europe

April 17th 2024
Article
Putting in practice retina innovations amid a pandemic

Putting in practice retina innovations amid a pandemic

August 28th 2020
Podcast
EyePoint shared additions to scientific advisory board and conditional approval of trade name for EYP-1901

EyePoint shared additions to scientific advisory board and conditional approval of trade name for EYP-1901

April 11th 2024
Article
EyePod

ASRS 2020: Evaluating 3-year-recurrence rate in non-infectious posterior segment uveitis post-FAi

July 29th 2020
Podcast
Clinical trials: Companies tackle AMD in early 2024

Clinical trials: Companies tackle AMD in early 2024

April 2nd 2024
Article
Understanding the risks: 4 factors that may contribute to AMD

Understanding the risks: 4 factors that may contribute to AMD

March 30th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.